http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105142637-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
filingDate 2014-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105142637-B
titleOfInvention Oral pharmaceutical composition containing rebamipide or its prodrug for preventing or treating dry eye
abstract The present invention discloses an oral pharmaceutical composition for preventing or treating dry eye. The oral pharmaceutical composition comprises rebamipide or its prodrug or its pharmaceutically acceptable salt as an active ingredient. The compounds can treat dry eye via the oral route and are therefore safer and more convenient to use than traditional eye drops.
priorityDate 2013-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419723178
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453727918
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584818
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118035543
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1117
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432582469
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118876087
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553254
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450602296
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411880054
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID118035534
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID160182734
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61163
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2909
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419551199
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154417
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9084
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454110021
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4766
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15039474
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512885
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154403700
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5042
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451718607
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507268
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88735
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457231771
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553082
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419543297

Total number of triples: 52.